| abstract |
The present application describes disubstituted pyrazolines and triazolines of formulae (I) and (II), or pharmaceutically acceptable salt forms thereof, wherein one of M?1 and M2¿ may be N and D may be a variety of N-containing groups, which are useful as inhibitors of factor Xa. |